摘要
目的分析、总结对子痫前期患者应用拉贝洛尔、硫酸镁联合治疗的临床效果。方法选取2012年9月至2018年9月在本院接受治疗的40例子痫前期患者进行观察,将应用拉贝洛尔单独治疗的20例患者作为参照组,将应用硫酸镁、拉贝洛尔联合治疗的20例患者作为联合组,观察对比两组治疗效果。结果经过治疗后,联合组24h尿蛋白定量(3.3±0.9)g、收缩压(130.9±9.1)mmHg、舒张压(80.8±6.4)mmHg,均明显低于参照组(P<0.05);联合组不良妊娠结局发生率为5.00%,明显低于对照组的35.00%,差异有统计学意义(P<0.05)。结论拉贝洛尔、硫酸镁联合治疗能有效控制患者血压水平及病情进展,改善母婴结局及预后,值得推广。
Objective To analyze and summarize the clinical effect of combined therapy of labetalol and magnesium sulfate for preeclampsia. Methods 40 patients with preeclampsia who were treated in our hospital from September 2012 to September 2018 were observed. 20 patients who were treated by Labellol alone were taken as the control group. 20 patients who were treated by magnesium sulfate and Labellol were taken as the combined group. The therapeutic effects of the two groups were observed and compared. Results After treatment, 24 hours urinary protein (3.3± 0.9) g, systolic blood pressure (130.9±9.1) mmHg and diastolic blood pressure (80.8±6.4) mmHg in the combined group were significantly lower than those in the control group (P<0.05), and the incidence of adverse pregnancy outcomes in the combined group was 5.00%, significantly lower than that in the control group (35.00%, P<0.05). Conclusion Labellol and magnesium sulfate combined with therapy can effectively control the blood pressure level and progress of the disease, improve maternal and infant outcomes and prognosis, which is worthy of promotion.
作者
吴巍
Wu Wei(Department of Obstetrics and Gynecology, Jiujiang Maternal and Child Health Hospital, Jiujiang, Jiangxi, 332000, China)
出处
《当代医学》
2019年第30期57-59,共3页
Contemporary Medicine
关键词
硫酸镁
子痫前期
拉贝洛尔
血压水平
不良妊娠
Magnesium sulfate
Preeclampsia
Labellol
Blood pressure level
Bad pregnancy
